Arrowstreet Capital’s MetLife MET Stock Holding History

Arrowstreet Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$219M	Buy	3,098,649 +1,771,689	+134%	+$133M	0.12%	165
2025 Q4	$105M	Buy	1,326,960 +759,360	+134%	+$60.1M	0.06%	287
2025 Q3	$46.8M	Buy	567,600 +150,085	+36%	+$11.8M	0.03%	470
2025 Q2	$33.6M	Buy	417,515 +272,619	+188%	+$21M	0.02%	530
2025 Q1	$11.6M	Sell	144,896 -119,007	-45%	-$9.9M	0.01%	762
2024 Q4	$21.6M	Sell	263,903 -478,065	-64%	-$39.8M	0.02%	584
2024 Q3	$61.2M	Buy	741,968 +450,929	+155%	+$33.7M	0.05%	296
2024 Q2	$20.4M	Buy	+291,039	New	+$20.8M	0.02%	475
2023 Q4	–	Sell	-1,841,853	Closed	-$116M	–	1501
2023 Q3	$116M	Buy	1,841,853 +102,404	+6%	+$6.38M	0.14%	146
2023 Q2	$98.3M	Buy	1,739,449 +886,909	+104%	+$49.2M	0.12%	164
2023 Q1	$49.4M	Buy	852,540 +841,707	+7,770%	+$56.8M	0.06%	270
2022 Q4	$784K	Sell	10,833 -183,611	-94%	-$13.2M	﹤0.01%	1063
2022 Q3	$11.8M	Buy	+194,444	New	+$12.4M	0.02%	494
2021 Q3	–	Sell	-21,300	Closed	-$1.27M	–	1749
2021 Q2	$1.27M	Buy	+21,300	New	+$1.35M	﹤0.01%	1473
2021 Q1	–	Sell	-47,602	Closed	-$2.23M	–	2412
2020 Q4	$2.23M	Sell	47,602 -3,946,289	-99%	-$171M	﹤0.01%	1559
2020 Q3	$148M	Sell	3,993,891 -554,967	-12%	-$21.1M	0.23%	75
2020 Q2	$166M	Buy	4,548,858 +987,705	+28%	+$34.4M	0.31%	55
2020 Q1	$109M	Buy	3,561,153 +257,428	+8%	+$11.4M	0.31%	58
2019 Q4	$168M	Sell	3,303,725 -257,209	-7%	-$12.4M	0.39%	50
2019 Q3	$168M	Buy	3,560,934 +1,498,430	+73%	+$71.4M	0.39%	65
2019 Q2	$102M	Buy	2,062,504 +1,804,524	+699%	+$84.8M	0.23%	101
2019 Q1	$11M	Buy	+257,980	New	+$11.4M	0.03%	534
2018 Q3	–	Sell	-112,600	Closed	-$4.91M	–	1185
2018 Q2	$4.91M	Buy	+112,600	New	+$5.25M	0.01%	549
2017 Q3	–	Sell	-1,568,893	Closed	-$76.8M	–	1179
2017 Q2	$76.8M	Buy	+1,568,893	New	+$72.8M	0.23%	119
2016 Q4	–	Sell	-2,488,872	Closed	-$98.6M	–	2189
2016 Q3	$98.6M	Sell	2,488,872 -1,492,530	-37%	-$56.1M	0.32%	68
2016 Q2	$141M	Buy	3,981,402 +2,030,770	+104%	+$79.2M	0.47%	50
2016 Q1	$76.4M	Sell	1,950,632 -1,900,618	-49%	-$71M	0.32%	71
2015 Q4	$165M	Buy	3,851,250 +293,389	+8%	+$12.9M	0.76%	24
2015 Q3	$150M	Buy	3,557,861 +1,945,757	+121%	+$90.9M	0.71%	28
2015 Q2	$80.4M	Buy	1,612,104 +344,008	+27%	+$16.3M	0.45%	59
2015 Q1	$57.1M	Sell	1,268,096 -1,069,794	-46%	-$48.1M	0.35%	72
2014 Q4	$113M	Buy	2,337,890 +972,499	+71%	+$46.2M	0.64%	33
2014 Q3	$65.4M	Buy	+1,365,391	New	+$66.3M	0.35%	76
2014 Q2	–	Sell	-60,340	Closed	-$2.84M	–	1103
2014 Q1	$2.84M	Sell	60,340 -1,756,076	-97%	-$80.7M	0.02%	575
2013 Q4	$87.3M	Buy	1,816,416 +1,549,162	+580%	+$69.4M	0.47%	57
2013 Q3	$11.2M	Buy	+267,254	New	+$11.5M	0.07%	244

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital's MET Position: Q1 2026 in Review

Arrowstreet Capital increased its MetLife (MET) stake by 134% in Q1 2026, buying an estimated $133M and bringing the position to 3,098,649 shares worth $219M. The position accounts for 0.12% of the portfolio, ranked #165.

Arrowstreet Capital first reported a position in MET in Q3 2013 and has held it in 36 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Arrowstreet Capital held 3,098,649 shares of MetLife worth $219M as of Q1 2026.
Arrowstreet Capital bought 1,771,689 MetLife shares in Q1 2026, an estimated $133M.
MetLife made up 0.12% of Arrowstreet Capital's portfolio in Q1 2026, its #165 holding.
Arrowstreet Capital first reported a position in MetLife in Q3 2013 and has held it in 36 quarters since.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.